A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age

L. Chang, P. L. Lee, Constantin Yiannoutsos, T. Ernst, C. M. Marra, T. Richards, D. Kolson, G. Schifitto, J. G. Jarvik, E. N. Miller, R. Lenkinski, G. Gonzalez, B. A. Navia

Research output: Contribution to journalArticle

141 Citations (Scopus)

Abstract

Objective: Differences in diagnostic criteria and methods have led to mixed results regarding the metabolite pattern of HIV-associated brain injury in relation to neurocognitive impairment. Therefore, a multicenter MRS consortium was formed to evaluate the neurometabolites in HIV patients with or without cognitive impairment. Methods: Proton magnetic resonance spectroscopy (MRS) at short-echo time (30 ms) was assessed in the frontal white matter, basal ganglia, and parietal cortex of 100 HIV patients [61 with AIDS dementia complex (ADC) and 39 neuroasymptomatic (NAS)] and 37 seronegative (SN) controls. Results: Compared to SN, NAS had higher glial marker myoinositol-to-creatine ratio (MI/Cr) in the white matter (multivariate analyses, adjusted P = 0.001), while ADC showed further increased MI/Cr in the white matter and basal ganglia (both P < 0.001), and increased choline compounds (Cho)/Cr in white matter (P = 0.04) and basal ganglia (P < 0.001). Compared to NAS, ADC showed a reduction in the neuronal marker N-acetyl compound (NA)/Cr in the frontal white matter (P = 0.007). CSF, but not plasma, viral load correlated with MI/Cr and Cho/Cr in white matter and NAA/Cr in parietal cortex. HIV infection and aging had additive effects on Cho/Cr and MI/Cr in the basal ganglia and white matter. Conclusions: The results suggest that glial activation occurs during the NAS stages of HIV infection, whereas further inflammatory activity in the basal ganglia and neuronal injury in the white matter is associated with the development of cognitive impairment. Aging may further exacerbate brain metabolites associated with inflammation in HIV patient and thereby increase the risk for cognitive impairment.

Original languageEnglish
Pages (from-to)1336-1347
Number of pages12
JournalNeuroImage
Volume23
Issue number4
DOIs
StatePublished - Dec 2004

Fingerprint

AIDS Dementia Complex
Basal Ganglia
Creatine
Inositol
HIV
Parietal Lobe
Neuroglia
HIV Infections
White Matter
Proton Magnetic Resonance Spectroscopy
Choline
Viral Load
Brain Injuries
Magnetic Resonance Spectroscopy
Multivariate Analysis
Inflammation

Keywords

  • Dementia
  • HIV
  • Inflammation
  • Neuroasymptomatic
  • Spectroscopy

ASJC Scopus subject areas

  • Cognitive Neuroscience
  • Neurology

Cite this

A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age. / Chang, L.; Lee, P. L.; Yiannoutsos, Constantin; Ernst, T.; Marra, C. M.; Richards, T.; Kolson, D.; Schifitto, G.; Jarvik, J. G.; Miller, E. N.; Lenkinski, R.; Gonzalez, G.; Navia, B. A.

In: NeuroImage, Vol. 23, No. 4, 12.2004, p. 1336-1347.

Research output: Contribution to journalArticle

Chang, L, Lee, PL, Yiannoutsos, C, Ernst, T, Marra, CM, Richards, T, Kolson, D, Schifitto, G, Jarvik, JG, Miller, EN, Lenkinski, R, Gonzalez, G & Navia, BA 2004, 'A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age', NeuroImage, vol. 23, no. 4, pp. 1336-1347. https://doi.org/10.1016/j.neuroimage.2004.07.067
Chang, L. ; Lee, P. L. ; Yiannoutsos, Constantin ; Ernst, T. ; Marra, C. M. ; Richards, T. ; Kolson, D. ; Schifitto, G. ; Jarvik, J. G. ; Miller, E. N. ; Lenkinski, R. ; Gonzalez, G. ; Navia, B. A. / A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age. In: NeuroImage. 2004 ; Vol. 23, No. 4. pp. 1336-1347.
@article{8d964c700ed24a98941f05f48bbdf57e,
title = "A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age",
abstract = "Objective: Differences in diagnostic criteria and methods have led to mixed results regarding the metabolite pattern of HIV-associated brain injury in relation to neurocognitive impairment. Therefore, a multicenter MRS consortium was formed to evaluate the neurometabolites in HIV patients with or without cognitive impairment. Methods: Proton magnetic resonance spectroscopy (MRS) at short-echo time (30 ms) was assessed in the frontal white matter, basal ganglia, and parietal cortex of 100 HIV patients [61 with AIDS dementia complex (ADC) and 39 neuroasymptomatic (NAS)] and 37 seronegative (SN) controls. Results: Compared to SN, NAS had higher glial marker myoinositol-to-creatine ratio (MI/Cr) in the white matter (multivariate analyses, adjusted P = 0.001), while ADC showed further increased MI/Cr in the white matter and basal ganglia (both P < 0.001), and increased choline compounds (Cho)/Cr in white matter (P = 0.04) and basal ganglia (P < 0.001). Compared to NAS, ADC showed a reduction in the neuronal marker N-acetyl compound (NA)/Cr in the frontal white matter (P = 0.007). CSF, but not plasma, viral load correlated with MI/Cr and Cho/Cr in white matter and NAA/Cr in parietal cortex. HIV infection and aging had additive effects on Cho/Cr and MI/Cr in the basal ganglia and white matter. Conclusions: The results suggest that glial activation occurs during the NAS stages of HIV infection, whereas further inflammatory activity in the basal ganglia and neuronal injury in the white matter is associated with the development of cognitive impairment. Aging may further exacerbate brain metabolites associated with inflammation in HIV patient and thereby increase the risk for cognitive impairment.",
keywords = "Dementia, HIV, Inflammation, Neuroasymptomatic, Spectroscopy",
author = "L. Chang and Lee, {P. L.} and Constantin Yiannoutsos and T. Ernst and Marra, {C. M.} and T. Richards and D. Kolson and G. Schifitto and Jarvik, {J. G.} and Miller, {E. N.} and R. Lenkinski and G. Gonzalez and Navia, {B. A.}",
year = "2004",
month = "12",
doi = "10.1016/j.neuroimage.2004.07.067",
language = "English",
volume = "23",
pages = "1336--1347",
journal = "NeuroImage",
issn = "1053-8119",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age

AU - Chang, L.

AU - Lee, P. L.

AU - Yiannoutsos, Constantin

AU - Ernst, T.

AU - Marra, C. M.

AU - Richards, T.

AU - Kolson, D.

AU - Schifitto, G.

AU - Jarvik, J. G.

AU - Miller, E. N.

AU - Lenkinski, R.

AU - Gonzalez, G.

AU - Navia, B. A.

PY - 2004/12

Y1 - 2004/12

N2 - Objective: Differences in diagnostic criteria and methods have led to mixed results regarding the metabolite pattern of HIV-associated brain injury in relation to neurocognitive impairment. Therefore, a multicenter MRS consortium was formed to evaluate the neurometabolites in HIV patients with or without cognitive impairment. Methods: Proton magnetic resonance spectroscopy (MRS) at short-echo time (30 ms) was assessed in the frontal white matter, basal ganglia, and parietal cortex of 100 HIV patients [61 with AIDS dementia complex (ADC) and 39 neuroasymptomatic (NAS)] and 37 seronegative (SN) controls. Results: Compared to SN, NAS had higher glial marker myoinositol-to-creatine ratio (MI/Cr) in the white matter (multivariate analyses, adjusted P = 0.001), while ADC showed further increased MI/Cr in the white matter and basal ganglia (both P < 0.001), and increased choline compounds (Cho)/Cr in white matter (P = 0.04) and basal ganglia (P < 0.001). Compared to NAS, ADC showed a reduction in the neuronal marker N-acetyl compound (NA)/Cr in the frontal white matter (P = 0.007). CSF, but not plasma, viral load correlated with MI/Cr and Cho/Cr in white matter and NAA/Cr in parietal cortex. HIV infection and aging had additive effects on Cho/Cr and MI/Cr in the basal ganglia and white matter. Conclusions: The results suggest that glial activation occurs during the NAS stages of HIV infection, whereas further inflammatory activity in the basal ganglia and neuronal injury in the white matter is associated with the development of cognitive impairment. Aging may further exacerbate brain metabolites associated with inflammation in HIV patient and thereby increase the risk for cognitive impairment.

AB - Objective: Differences in diagnostic criteria and methods have led to mixed results regarding the metabolite pattern of HIV-associated brain injury in relation to neurocognitive impairment. Therefore, a multicenter MRS consortium was formed to evaluate the neurometabolites in HIV patients with or without cognitive impairment. Methods: Proton magnetic resonance spectroscopy (MRS) at short-echo time (30 ms) was assessed in the frontal white matter, basal ganglia, and parietal cortex of 100 HIV patients [61 with AIDS dementia complex (ADC) and 39 neuroasymptomatic (NAS)] and 37 seronegative (SN) controls. Results: Compared to SN, NAS had higher glial marker myoinositol-to-creatine ratio (MI/Cr) in the white matter (multivariate analyses, adjusted P = 0.001), while ADC showed further increased MI/Cr in the white matter and basal ganglia (both P < 0.001), and increased choline compounds (Cho)/Cr in white matter (P = 0.04) and basal ganglia (P < 0.001). Compared to NAS, ADC showed a reduction in the neuronal marker N-acetyl compound (NA)/Cr in the frontal white matter (P = 0.007). CSF, but not plasma, viral load correlated with MI/Cr and Cho/Cr in white matter and NAA/Cr in parietal cortex. HIV infection and aging had additive effects on Cho/Cr and MI/Cr in the basal ganglia and white matter. Conclusions: The results suggest that glial activation occurs during the NAS stages of HIV infection, whereas further inflammatory activity in the basal ganglia and neuronal injury in the white matter is associated with the development of cognitive impairment. Aging may further exacerbate brain metabolites associated with inflammation in HIV patient and thereby increase the risk for cognitive impairment.

KW - Dementia

KW - HIV

KW - Inflammation

KW - Neuroasymptomatic

KW - Spectroscopy

UR - http://www.scopus.com/inward/record.url?scp=13844310730&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13844310730&partnerID=8YFLogxK

U2 - 10.1016/j.neuroimage.2004.07.067

DO - 10.1016/j.neuroimage.2004.07.067

M3 - Article

C2 - 15589098

AN - SCOPUS:13844310730

VL - 23

SP - 1336

EP - 1347

JO - NeuroImage

JF - NeuroImage

SN - 1053-8119

IS - 4

ER -